(Reuters) – Protection against COVID-19 from an mRNA vaccine – either the Moderna or Pfizer/BioNTech shots – may last longer after the booster dose than after the original two-shot regimen, researchers speculated based on the results of a small new study.They measured vaccine responses before and after the boosters in 33 healthy middle-aged adults who had received their second doses an average of nine months earlier.webmd.ads2.defineAd({id:’ads-pos-1122′,pos: 1122});Before the boosters, antibody levels had decreased about 10-fold from levels early after the second dose. By 6 to 10 days after the booster, average antibody levels had climbed 25-fold and were five times higher than after two doses of the vaccine, according to a report posted on medRxiv ahead of peer review.In the volunteers who had COVID-19 before being vaccinated, antibody levels after the booster were 50-fold higher than after their infections.

webmd.ads2.defineAd({id:’ads-pos-520′,pos: 520});”Because these antibody levels are so robust, the booster could potentially give us protection for a longer duration than what we saw for two doses of the vaccine,” study coauthor Alexis Demonbreun of Northwestern University Feinberg School of Medicine in Chicago, said in a statement.

webmd.ads2.defineAd({id:’ads-pos-1520′,pos: 1520});SOURCE: https://bit.ly/3lbTcQo medRxiv, online November 21, 2021.

3

Reuters Health Information © 2021 

TOP PICKS FOR YOU

webmd.ads2.defineAd({
id: ‘ads-pos-904’,
pos: 904
});

webmd.ads2.defineAd({
id: ‘ads-pos-906’,
pos: 906
});

webmd.ads2.defineAd({
id: ‘ads-pos-907’,
pos: 907
});